ArticleScientific reports2025
Elucidation of the effects of caffeine consumption on estrous cycle, hematology, and lipid profile of female Wistar rats.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Isorhamnetin-preconditioned MSC-derived exosomes restore ovarian function by inhibiting ferroptosis in chemotherapy-induced POF.Stem cell research & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The consumption of caffeinated beverages has become deeply ingrained in modern society, with coffee, tea, and energy drinks being among the most commonly consumed sources of caffeine. Its physiological effects on the cardio-metabolic system have been reported in males. Hematological parameters and lipid profiling are crucial in the diagnosis of cardio-metabolic disorders. Given the growing prevalence of cardiovascular diseases among women and the potential role of caffeine consumption in modulating lipid profiles and hematopoiesis, a comprehensive investigation into this relationship was warranted using a female animal model. The phase of recovery from its effects was also considered in this study. Thirty-five adult female Wistar rats were randomly divided into seven groups (n = 5). Group I was the control and received distilled water (0.2 mL/Kg/day). Groups II-IV received daily oral doses of caffeine (10, 20, and 40 mg/Kg/day, respectively) for 21 days. Groups V-VII received similar caffeine doses for 21 days, followed by a 21-day withdrawal (recovery) period. The estrous cycle was assessed by unstained and staining techniques, full blood indices was determined by a hematology analyzer. Serum Tumor necrotic factor-alpha (TNF-α), lipid and hormonal profiles were assayed by ELISA techniques. Statistical analysis employed one way ANOVA with significance taken at p < 0.05. The findings of this study showed that caffeine reduced the kidney and liver weights, reduced white blood cell count, Gonadotropin releasing hormone level and further irreversibly reduced progesterone levels, but maintained the lipid profile level. Caffeine increased the level of TNF-α, but adversely impacted the phases of the estrous cycle by reducing their occurrences. These alterations were however reversed during withdrawal from caffeine. Hence, this study highlights that though caffeine may impact immune function, cardiovascular, reproductive and metabolic health, the withdrawal or stoppage of its intake can result in restoration of the altered changes in the body overtime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.